ARMP Armata Pharmaceuticals Inc

Price (delayed)

$4.82

Market cap

$179.22M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$5.31

Enterprise value

$465.1M

?
Relative Growth: Rel. Growth: 6
Relative Strength: Rel. Strength: 21
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 0

Armata is a late clinical-stage biotechnology company focused on the development of high-purity pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. ...

Highlights
The company's net income rose by 32% QoQ
Armata Pharmaceuticals's EPS has increased by 32% QoQ
The company's debt has surged by 118% YoY but it fell by 16% QoQ
The company's quick ratio has shrunk by 88% QoQ but it rose by 20% YoY

Key stats

What are the main financial stats of ARMP

ARMP stock price

How has the Armata Pharmaceuticals stock price performed over time
Intraday
11.83%
1 week
2.55%
1 month
21.41%
1 year
92.8%
YTD
-23.25%
QTD
-25.62%

Financial performance

How have Armata Pharmaceuticals's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$46.24M
Net income
-$192.18M
Gross margin
N/A
Net margin
N/A
The company's net income rose by 32% QoQ
Armata Pharmaceuticals's operating income has decreased by 10% YoY and by 9% QoQ

Price vs fundamentals

How does ARMP's price correlate with its fundamentals

Growth

What is Armata Pharmaceuticals's growth rate over time

Valuation

What is Armata Pharmaceuticals stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Armata Pharmaceuticals's EPS has increased by 32% QoQ
The equity has grown by 26% from the previous quarter

Efficiency

How efficient is Armata Pharmaceuticals business performance
ARMP's return on invested capital is up by 37% since the previous quarter
Armata Pharmaceuticals's ROA has increased by 34% from the previous quarter

Dividends

What is ARMP's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ARMP.

Financial health

How did Armata Pharmaceuticals financials performed over time
ARMP's total assets is 72% lower than its total liabilities
The company's total liabilities has surged by 114% YoY but it fell by 16% QoQ
The company's quick ratio has shrunk by 88% QoQ but it rose by 20% YoY
The company's debt has surged by 118% YoY but it fell by 16% QoQ
ARMP's debt to equity is up by 34% year-on-year but it is down by 13% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.